Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Real-world analysis of Hodgkin lymphoma outcomes after auto-SCT

Ali Bazarbachi, MD, PhD, American University of Beirut Medical Center, Beirut, Lebanon, discusses the evolution of outcomes over time for relapsed Hodgkin lymphoma (HL) after autologous stem cell transplantation (auto-SCT). Real-world data from 1781 HL patients in the European Blood and Marrow Transplant (EBMT) registry was analyzed to assess the prognosis of patients with recurrent-HL post-auto-SCT. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.